Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of clarity over its revenue outlook. Read more here.

The report comes as tech stocks, led by the Magnificent Seven—think Apple, Microsoft, Google, and their mega-cap friends—take a hit after DeepSeek’s debut.

Goldman Sachs reaffirmed its Neutral stance on SoFi Technologies stock (NASDAQ:SOFI), maintaining a price target of $9.50. Following the release of the company's fourth-quarter results for the year 2024,

We recently compiled a list of the Top 10 AI Stocks Dominating Wall Street. In this article, we are going to take a look at where Tesla, Inc. (NASDAQ:TSLA) stands against the other AI stocks. The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley.

Goldman Sachs has initiated coverage of Vera Therapeutics (NASDAQ:VERA) with a buy rating, citing the potential of its drug candidate atacicept and a recent pullback in the stock. The investment bank said it views atacicept as "largely de-risked,

Its shares were listed on the Nasdaq for the public to trade in 2024. Brightspring stock has more than doubled over the past 10 months but Goldman Sachs analysts continue to see further upside in it as the population ages. In November, the $3.2 billion ...

Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China's new AI model was emerging to challenge U.S. dominance in the sector, a Goldman Sachs note said.

NCPRR and NLPC sent Goldman and JPMorgan the anti-DEI proposals, while Bank of America and Citi received proposals from NLPC and The Heritage Foundation asking them to audit whether they have surveilled customers based on their political and religious beliefs, according to the Journal.

Goldman Sachs reiterated its Sell rating on Jack Henry (NASDAQ:JKHY) with a steady price target of $175.00. According to InvestingPro data, the stock currently trades at $177.60 with a P/E ratio of 32.

JetBlue anticipates unit costs excluding fuel (CASM ex-fuel) to rise by 5% to 7% year-over-year with flat capacity. This forecast is consistent with prior management commentary and consensus expectations,

Goldman Sachs analyst Michael Ng increased the price target on Axon Enterprise (NASDAQ:AXON) shares to $700 from the previous $500, while reiterating a Buy rating on the stock. Currently trading at $610.